Loading…
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
Objective: Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combination of specific inflammatory markers into an RCC Inf...
Saved in:
Published in: | Asian Journal of Urology 2017-10, Vol.4 (4), p.230-238 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c521t-f0cf899785c1146849f7a867192a84d76dbaf0f50f0e2e2c5c8587aa6dbf5bd13 |
---|---|
cites | |
container_end_page | 238 |
container_issue | 4 |
container_start_page | 230 |
container_title | Asian Journal of Urology |
container_volume | 4 |
creator | Sekar, Rishi R. Patil, Dattatraya Baum, Yoram Pearl, Jeffrey Bausum, Anna Bilen, Mehmet A. Kucuk, Omer Harris, Wayne B. Carthon, Bradley C. Alemozaffar, Mehrdad Filson, Christopher P. Pattaras, John G. Nieh, Peter T. Ogan, Kenneth Master, Viraj A. |
description | Objective: Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combination of specific inflammatory markers into an RCC Inflammatory Score (RISK) could serve as a rigorous prognostic indicator of overall survival (OS) in patients with clear cell and non-clear cell RCC. Methods: Combination of preoperative C-reactive protein (CRP), albumin, erythrocyte sedimentation rate (ESR), corrected calcium, and aspartate transaminase to alanine transaminase (AST/ALT) ratio was used to develop RISK. RISK was developed using grid-search methodology, receiver-operating-characteristic (ROC) analysis, and sensitivity-specificity trade-off analysis. Prognostic value of RISK was analyzed using the Kaplan–Meier method and Cox proportional regression models. Predictive accuracy was compared with RISK to Size, Size, Grade, and Necrosis (SSIGN) score, University of California-LOS Angeles (UCLA) Integrated Staging System (UISS), and Leibovich Prognosis Score (LPS). Results: Among 391 RCC patients treated with nephrectomy, area under the curve (AUC) for RISK was 0.783, which was comparable to SSIGN (AUC 0.776, p = 0.82) and UISS (AUC 0.809, p = 0.317). Among patients with localized disease, AUC for RISK and LPS was 0.742 and 0.706, respectively (p = 0.456). On multivariate analysis, we observed a step-wise statistically significant inverse relationship between increasing RISK group and OS (all p |
doi_str_mv | 10.1016/j.ajur.2017.04.002 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5773049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c52e52aa4f834a8889b9e302f85ca1c4</doaj_id><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5773049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-f0cf899785c1146849f7a867192a84d76dbaf0f50f0e2e2c5c8587aa6dbf5bd13</originalsourceid><addsrcrecordid>eNpVj91KxDAQhYMoKuoLeJUX2JqkySa5EUT8WRC80esym052s6ZNSev68_RmVQRvZoYzH-fMEHLOWcUZn19sKti85kowrismK8bEHjkWgstZbSzb_5uNOCJn47hhrJC2VpYfkiNha6OVUsfk_Yr2aYuRDhnTgBmmsEUaeh-h62BK-YN2kF8wFyCt-jROwdHRpbyD6FBw7KeRvoVpTWNyEMMnthT6lnY4wTjBjs_YQ6QOYymQXehTB6fkwEMc8ey3n5Dn25un6_vZw-Pd4vrqYeaU4NPMM-eNtdoox7mcG2m9BjPX3AowstXzdgmeecU8Q4HCKWeU0QBF92rZ8vqELH582wSbZsihvPPRJAjNt5DyqoFcjozYlERUAkB6U0swxtilxZoJX8KBO1m8Ln-8htdlh60rr2eI_0z_b_qwblZp2yitayZt_QWAH4ld</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma</title><source>ScienceDirect®</source><source>PubMed Central</source><creator>Sekar, Rishi R. ; Patil, Dattatraya ; Baum, Yoram ; Pearl, Jeffrey ; Bausum, Anna ; Bilen, Mehmet A. ; Kucuk, Omer ; Harris, Wayne B. ; Carthon, Bradley C. ; Alemozaffar, Mehrdad ; Filson, Christopher P. ; Pattaras, John G. ; Nieh, Peter T. ; Ogan, Kenneth ; Master, Viraj A.</creator><creatorcontrib>Sekar, Rishi R. ; Patil, Dattatraya ; Baum, Yoram ; Pearl, Jeffrey ; Bausum, Anna ; Bilen, Mehmet A. ; Kucuk, Omer ; Harris, Wayne B. ; Carthon, Bradley C. ; Alemozaffar, Mehrdad ; Filson, Christopher P. ; Pattaras, John G. ; Nieh, Peter T. ; Ogan, Kenneth ; Master, Viraj A.</creatorcontrib><description>Objective: Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combination of specific inflammatory markers into an RCC Inflammatory Score (RISK) could serve as a rigorous prognostic indicator of overall survival (OS) in patients with clear cell and non-clear cell RCC. Methods: Combination of preoperative C-reactive protein (CRP), albumin, erythrocyte sedimentation rate (ESR), corrected calcium, and aspartate transaminase to alanine transaminase (AST/ALT) ratio was used to develop RISK. RISK was developed using grid-search methodology, receiver-operating-characteristic (ROC) analysis, and sensitivity-specificity trade-off analysis. Prognostic value of RISK was analyzed using the Kaplan–Meier method and Cox proportional regression models. Predictive accuracy was compared with RISK to Size, Size, Grade, and Necrosis (SSIGN) score, University of California-LOS Angeles (UCLA) Integrated Staging System (UISS), and Leibovich Prognosis Score (LPS). Results: Among 391 RCC patients treated with nephrectomy, area under the curve (AUC) for RISK was 0.783, which was comparable to SSIGN (AUC 0.776, p = 0.82) and UISS (AUC 0.809, p = 0.317). Among patients with localized disease, AUC for RISK and LPS was 0.742 and 0.706, respectively (p = 0.456). On multivariate analysis, we observed a step-wise statistically significant inverse relationship between increasing RISK group and OS (all p < 0.001). Conclusion: RISK is an independent and significant predictor of OS for patients treated with nephrectomy for clear cell and non-clear cell RCC, with accuracy comparable to other histopathological prognostic tools.</description><identifier>ISSN: 2214-3882</identifier><identifier>EISSN: 2214-3890</identifier><identifier>DOI: 10.1016/j.ajur.2017.04.002</identifier><identifier>PMID: 29387555</identifier><language>eng</language><publisher>Second Military Medical University</publisher><subject>Biomarker ; Inflammation ; Original ; Prognosis ; Renal cell carcinoma</subject><ispartof>Asian Journal of Urology, 2017-10, Vol.4 (4), p.230-238</ispartof><rights>2017 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. 2017 Editorial Office of Asian Journal of Urology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-f0cf899785c1146849f7a867192a84d76dbaf0f50f0e2e2c5c8587aa6dbf5bd13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773049/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773049/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Sekar, Rishi R.</creatorcontrib><creatorcontrib>Patil, Dattatraya</creatorcontrib><creatorcontrib>Baum, Yoram</creatorcontrib><creatorcontrib>Pearl, Jeffrey</creatorcontrib><creatorcontrib>Bausum, Anna</creatorcontrib><creatorcontrib>Bilen, Mehmet A.</creatorcontrib><creatorcontrib>Kucuk, Omer</creatorcontrib><creatorcontrib>Harris, Wayne B.</creatorcontrib><creatorcontrib>Carthon, Bradley C.</creatorcontrib><creatorcontrib>Alemozaffar, Mehrdad</creatorcontrib><creatorcontrib>Filson, Christopher P.</creatorcontrib><creatorcontrib>Pattaras, John G.</creatorcontrib><creatorcontrib>Nieh, Peter T.</creatorcontrib><creatorcontrib>Ogan, Kenneth</creatorcontrib><creatorcontrib>Master, Viraj A.</creatorcontrib><title>A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma</title><title>Asian Journal of Urology</title><description>Objective: Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combination of specific inflammatory markers into an RCC Inflammatory Score (RISK) could serve as a rigorous prognostic indicator of overall survival (OS) in patients with clear cell and non-clear cell RCC. Methods: Combination of preoperative C-reactive protein (CRP), albumin, erythrocyte sedimentation rate (ESR), corrected calcium, and aspartate transaminase to alanine transaminase (AST/ALT) ratio was used to develop RISK. RISK was developed using grid-search methodology, receiver-operating-characteristic (ROC) analysis, and sensitivity-specificity trade-off analysis. Prognostic value of RISK was analyzed using the Kaplan–Meier method and Cox proportional regression models. Predictive accuracy was compared with RISK to Size, Size, Grade, and Necrosis (SSIGN) score, University of California-LOS Angeles (UCLA) Integrated Staging System (UISS), and Leibovich Prognosis Score (LPS). Results: Among 391 RCC patients treated with nephrectomy, area under the curve (AUC) for RISK was 0.783, which was comparable to SSIGN (AUC 0.776, p = 0.82) and UISS (AUC 0.809, p = 0.317). Among patients with localized disease, AUC for RISK and LPS was 0.742 and 0.706, respectively (p = 0.456). On multivariate analysis, we observed a step-wise statistically significant inverse relationship between increasing RISK group and OS (all p < 0.001). Conclusion: RISK is an independent and significant predictor of OS for patients treated with nephrectomy for clear cell and non-clear cell RCC, with accuracy comparable to other histopathological prognostic tools.</description><subject>Biomarker</subject><subject>Inflammation</subject><subject>Original</subject><subject>Prognosis</subject><subject>Renal cell carcinoma</subject><issn>2214-3882</issn><issn>2214-3890</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVj91KxDAQhYMoKuoLeJUX2JqkySa5EUT8WRC80esym052s6ZNSev68_RmVQRvZoYzH-fMEHLOWcUZn19sKti85kowrismK8bEHjkWgstZbSzb_5uNOCJn47hhrJC2VpYfkiNha6OVUsfk_Yr2aYuRDhnTgBmmsEUaeh-h62BK-YN2kF8wFyCt-jROwdHRpbyD6FBw7KeRvoVpTWNyEMMnthT6lnY4wTjBjs_YQ6QOYymQXehTB6fkwEMc8ey3n5Dn25un6_vZw-Pd4vrqYeaU4NPMM-eNtdoox7mcG2m9BjPX3AowstXzdgmeecU8Q4HCKWeU0QBF92rZ8vqELH582wSbZsihvPPRJAjNt5DyqoFcjozYlERUAkB6U0swxtilxZoJX8KBO1m8Ln-8htdlh60rr2eI_0z_b_qwblZp2yitayZt_QWAH4ld</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Sekar, Rishi R.</creator><creator>Patil, Dattatraya</creator><creator>Baum, Yoram</creator><creator>Pearl, Jeffrey</creator><creator>Bausum, Anna</creator><creator>Bilen, Mehmet A.</creator><creator>Kucuk, Omer</creator><creator>Harris, Wayne B.</creator><creator>Carthon, Bradley C.</creator><creator>Alemozaffar, Mehrdad</creator><creator>Filson, Christopher P.</creator><creator>Pattaras, John G.</creator><creator>Nieh, Peter T.</creator><creator>Ogan, Kenneth</creator><creator>Master, Viraj A.</creator><general>Second Military Medical University</general><general>Elsevier</general><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20171001</creationdate><title>A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma</title><author>Sekar, Rishi R. ; Patil, Dattatraya ; Baum, Yoram ; Pearl, Jeffrey ; Bausum, Anna ; Bilen, Mehmet A. ; Kucuk, Omer ; Harris, Wayne B. ; Carthon, Bradley C. ; Alemozaffar, Mehrdad ; Filson, Christopher P. ; Pattaras, John G. ; Nieh, Peter T. ; Ogan, Kenneth ; Master, Viraj A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-f0cf899785c1146849f7a867192a84d76dbaf0f50f0e2e2c5c8587aa6dbf5bd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biomarker</topic><topic>Inflammation</topic><topic>Original</topic><topic>Prognosis</topic><topic>Renal cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sekar, Rishi R.</creatorcontrib><creatorcontrib>Patil, Dattatraya</creatorcontrib><creatorcontrib>Baum, Yoram</creatorcontrib><creatorcontrib>Pearl, Jeffrey</creatorcontrib><creatorcontrib>Bausum, Anna</creatorcontrib><creatorcontrib>Bilen, Mehmet A.</creatorcontrib><creatorcontrib>Kucuk, Omer</creatorcontrib><creatorcontrib>Harris, Wayne B.</creatorcontrib><creatorcontrib>Carthon, Bradley C.</creatorcontrib><creatorcontrib>Alemozaffar, Mehrdad</creatorcontrib><creatorcontrib>Filson, Christopher P.</creatorcontrib><creatorcontrib>Pattaras, John G.</creatorcontrib><creatorcontrib>Nieh, Peter T.</creatorcontrib><creatorcontrib>Ogan, Kenneth</creatorcontrib><creatorcontrib>Master, Viraj A.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Asian Journal of Urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sekar, Rishi R.</au><au>Patil, Dattatraya</au><au>Baum, Yoram</au><au>Pearl, Jeffrey</au><au>Bausum, Anna</au><au>Bilen, Mehmet A.</au><au>Kucuk, Omer</au><au>Harris, Wayne B.</au><au>Carthon, Bradley C.</au><au>Alemozaffar, Mehrdad</au><au>Filson, Christopher P.</au><au>Pattaras, John G.</au><au>Nieh, Peter T.</au><au>Ogan, Kenneth</au><au>Master, Viraj A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma</atitle><jtitle>Asian Journal of Urology</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>4</volume><issue>4</issue><spage>230</spage><epage>238</epage><pages>230-238</pages><issn>2214-3882</issn><eissn>2214-3890</eissn><abstract>Objective: Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combination of specific inflammatory markers into an RCC Inflammatory Score (RISK) could serve as a rigorous prognostic indicator of overall survival (OS) in patients with clear cell and non-clear cell RCC. Methods: Combination of preoperative C-reactive protein (CRP), albumin, erythrocyte sedimentation rate (ESR), corrected calcium, and aspartate transaminase to alanine transaminase (AST/ALT) ratio was used to develop RISK. RISK was developed using grid-search methodology, receiver-operating-characteristic (ROC) analysis, and sensitivity-specificity trade-off analysis. Prognostic value of RISK was analyzed using the Kaplan–Meier method and Cox proportional regression models. Predictive accuracy was compared with RISK to Size, Size, Grade, and Necrosis (SSIGN) score, University of California-LOS Angeles (UCLA) Integrated Staging System (UISS), and Leibovich Prognosis Score (LPS). Results: Among 391 RCC patients treated with nephrectomy, area under the curve (AUC) for RISK was 0.783, which was comparable to SSIGN (AUC 0.776, p = 0.82) and UISS (AUC 0.809, p = 0.317). Among patients with localized disease, AUC for RISK and LPS was 0.742 and 0.706, respectively (p = 0.456). On multivariate analysis, we observed a step-wise statistically significant inverse relationship between increasing RISK group and OS (all p < 0.001). Conclusion: RISK is an independent and significant predictor of OS for patients treated with nephrectomy for clear cell and non-clear cell RCC, with accuracy comparable to other histopathological prognostic tools.</abstract><pub>Second Military Medical University</pub><pmid>29387555</pmid><doi>10.1016/j.ajur.2017.04.002</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2214-3882 |
ispartof | Asian Journal of Urology, 2017-10, Vol.4 (4), p.230-238 |
issn | 2214-3882 2214-3890 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5773049 |
source | ScienceDirect®; PubMed Central |
subjects | Biomarker Inflammation Original Prognosis Renal cell carcinoma |
title | A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T09%3A38%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20preoperative%20inflammatory%20marker%20prognostic%20score%20in%20patients%20with%20localized%20and%20metastatic%20renal%20cell%20carcinoma&rft.jtitle=Asian%20Journal%20of%20Urology&rft.au=Sekar,%20Rishi%20R.&rft.date=2017-10-01&rft.volume=4&rft.issue=4&rft.spage=230&rft.epage=238&rft.pages=230-238&rft.issn=2214-3882&rft.eissn=2214-3890&rft_id=info:doi/10.1016/j.ajur.2017.04.002&rft_dat=%3Cpubmedcentral_doaj_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5773049%3C/pubmedcentral_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-f0cf899785c1146849f7a867192a84d76dbaf0f50f0e2e2c5c8587aa6dbf5bd13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/29387555&rfr_iscdi=true |